MyJournals Home  

RSS FeedsCombination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors (Cancer Cell)

 
 

12 november 2019 01:03:44

 
Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors (Cancer Cell)
 


Checkpoint blockade (CPB) therapy can elicit durable clinical responses by reactivating an exhausted immune response. However, response rates remain limited, likely secondary to a lack of a tumor-reactive immune infiltrate. Chimeric antigen receptor (CAR) T cells may provide the necessary tumor-targeting immune infiltrate and a highly specific antitumor immune response. This can be further amplified by the addition of CPB agents, which serve to counteract the immune inhibitory environment undermining optimal CAR T cell efficacy.


 
233 viewsCategory: Cell Biology, Oncology
 
Stressing Out about Cancer Immunotherapy (Cancer Cell)
Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy (Cancer Cell)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Oncology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten